Literature DB >> 7327385

Oral ursodeoxycholic acid tolerance test in patients with digestive disease.

Y Yamanishi, Y Kishimoto, H Kawasaki, C Hirayama, S Ikawa.   

Abstract

Serial measurement of serum bile acid levels was carried out in patients with digestive diseases before and after oral loading with 500 mg of ursodeoxycholic acid. In control cases, serum bile acid reached the maximum level 30 min after loading. Elevation also, of cholic, chenodeoxycholic and deoxycholic acid levels was noted in addition to marked enhancement of the ursodeoxycholic acid level. In patients with chronic aggressive hepatitis and cirrhosis, the serum bile acid level was higher than the controls in fasting state, and increased more significantly after loading. On the other hand, in patients with small intestinal disorders, the serum bile acid level in fasting state tended to be lower than the controls, and became significantly lower after loading. Thus, oral ursodeoxycholic acid tolerance test is found to be useful as a diagnostic test for digestive diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7327385     DOI: 10.1007/bf02774519

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  14 in total

1.  Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease.

Authors:  B Thjodleifsson; S Barnes; A Chitranukroh; B H Billing; S Sherlock
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

Review 2.  The enterohepatic circulation of bile salts in gastrointestinal disorders.

Authors:  J T Garbutt; L Lack; M P Tyor
Journal:  Am J Med       Date:  1971-11       Impact factor: 4.965

3.  Postprandial serum bile acid for the detection of hepatobiliary disease.

Authors:  N Kaplowitz; E Kok; N B Javitt
Journal:  JAMA       Date:  1973-07-16       Impact factor: 56.272

4.  Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

Authors:  I Makino; S Nakagawa; K Mashimo
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

5.  The metabolism of intravenously injected isotopic cholic acid in Laennec's cirrhosis.

Authors:  M Blum; N Spritz
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

6.  Radioimmunoassay of ursodeoxycholic acid in serum.

Authors:  I Makino; A Tashiro; H Hashimoto; S Nakagawa; I Yoshizawa
Journal:  J Lipid Res       Date:  1978-05       Impact factor: 5.922

7.  Enzyme-linked immunoassay of ursodeoxycholic acid in serum.

Authors:  S Ozaki; A Tashiro; I Makino; S Nakagawa; I Yoshizawa
Journal:  J Lipid Res       Date:  1979-02       Impact factor: 5.922

8.  Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption.

Authors:  N F LaRusso; M G Korman; N E Hoffman; A F Hofmann
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

9.  Total plasma bile acid concentration in chronic hepatitis and cirrhosis; fasting values and effect of intraduodenal bile salt administration.

Authors:  B Franz; J C Bode
Journal:  Klin Wochenschr       Date:  1974-06-01

10.  Diagnostic significance of fasting serum bile acid in liver disease.

Authors:  C Hirayama; T Irisa; K Arimura; M Nakamura
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1976 Nov-Dec
View more
  2 in total

1.  Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.

Authors:  Y Yamanishi; Y Nosaka; H Kawasaki; C Hirayama; S Ikawa
Journal:  Gastroenterol Jpn       Date:  1985-06

2.  Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.

Authors:  M Kadohara; H Kawasaki; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1987-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.